Keros Therapeutics, Inc. (KROS): SCHEDULE 13G filed May 15, 2026

Form type

SCHEDULE 13G

Filing date

May 15, 2026

Accession number

0001104659-26-062702

Filer

Keros Therapeutics, Inc. (CIK 1664710)